Search by Drug Name or NDC
NDC 65162-0890-23 Olopatadine Hydrochloride 665 ug/1 Details
Olopatadine Hydrochloride 665 ug/1
Olopatadine Hydrochloride is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is OLOPATADINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Olopatadine nasal spray is used to relieve sneezing and a stuffy, runny or itchy nose caused by allergic rhinitis (hay fever). Olopatadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms.
Related Packages: 65162-0890-23Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Olopatadine Nasal Spray
Product Information
| NDC | 65162-0890 |
|---|---|
| Product ID | 65162-890_359c7188-43da-41e3-9201-436f9568d454 |
| Associated GPIs | 42401060102020 |
| GCN Sequence Number | 063890 |
| GCN Sequence Number Description | olopatadine HCl SPRAY/PUMP 0.6 % NASAL |
| HIC3 | Q7E |
| HIC3 Description | NASAL ANTIHISTAMINE |
| GCN | 99602 |
| HICL Sequence Number | 012815 |
| HICL Sequence Number Description | OLOPATADINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Olopatadine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Olopatadine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 665 |
| Active Ingredient Units | ug/1 |
| Substance Name | OLOPATADINE HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA210901 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65162-0890-23 (65162089023)
| NDC Package Code | 65162-890-23 |
|---|---|
| Billing NDC | 65162089023 |
| Package | 1 BOTTLE, SPRAY in 1 CARTON (65162-890-23) / 665 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Marketing Start Date | 2020-02-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.10226 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | OLOPATADINE 665 MCG NASAL SPRY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis